Ismigen 7mg tbl bodyas N10

Prescription drug

Manufacturer: Штада
Рецептурный препарат
исмиген 7мг тбл подъяз n10
Product is available in pharmacies:
Choose a pharmacy where you would like to pick up the goods
620,00 rub.
+ 13 bonuses на карту
- +
Add to cart
All products in the order are reserved for 24 hours,
after that the order is automatically canceled
Brief information



Действующее вещество

Лизатов бактерий смесь

The appearance of the product may differ from the photos on the site.

General description
Источник:  РЛС


Sublingual tablets1 table.
active substance: 
lyophilized bacterial lysates50 mg
(incl. active ingredients: lysates of bacteria Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae (types TY1/EQ11, TY2/EQ22, TY3/EQ14, TY5/EQ15, TY8/EQ23, TY47/EQ24), Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae b, Neisseria catarrhalis — 7 mg; excipients: glycine — 43 mg) 
excipients: MCC-150 mg; calcium hydrophosphate dihydrate-35 mg; silicon dioxide colloidal-10 mg; magnesium stearate-3 mg; ammonium glycyrrhizinate-1.2 mg; mint flavor-0.8 mg 

Description of the dosage form

Tablets are flat-cylindrical with a risk, light cream color, with brown inclusions and a faint smell of mint.


Combined immunostimulating drug of bacterial origin for sublingual (sublingual) administration. It is a polyvalent antigen complex that includes lysates of bacteria — the most common pathogens of respiratory infections. Lysates that are part of the drug Ismigen are obtained by mechanical destruction of bacterial cells.

The drug Ismigen has a non-specific immunostimulating and specific vaccination effect on various parts of the immune system. It stimulates both local (increases the concentration of secretory IgA) and systemic (cellular and humoral) immunity. Activates phagocytosis, increases the content of lysozyme in saliva, increases the number of immunocompetent cells, increases the concentration of serum IgA, IgG, IgM and reduces the concentration of serum IgE.

Increases the functional activity of macrophages (including alveolar) and polymorphonuclear leukocytes, which contributes to the destruction of infectious agents.

As a result of treatment with Ismigen, the frequency, severity and duration of acute respiratory tract infections are reduced; there is relief and leveling of symptoms such as fever, cough, shortness of breath, and the need for antibacterial and anti-inflammatory therapy is reduced; in patients with chronic respiratory tract diseases, the drug also prevents exacerbations.

Indications of the drug

acute and subacute upper and lower respiratory tract infections: bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis, including complications after influenza (treatment in combination therapy);

recurrent upper and lower respiratory tract infections, chronic bronchitis (prevention of exacerbations).


hypersensitivity to the active and / or auxiliary components of the drug;


breastfeeding period;

children under 3 years of age.

Use during pregnancy and lactation


Dosage and administration

Sublingual, on an empty stomach. The tablet should be kept under the tongue until completely dissolved. Sublingual tablets should not be absorbed, chewed or swallowed.

Acute and subacute upper and lower respiratory tract infections. 1 table./day until symptoms disappear (at least 10 days).

Recurrent upper and lower respiratory tract infections, prevention of exacerbations of chronic respiratory diseases. 1 table./day for 10 days. The preventive course includes 3 cycles of 10 days with 20-day intervals between them. The preventive course should be carried out no more than 1-2 times a year.

If you skip the next dose, do not double it at the next dose.

If there is no improvement after treatment, or if symptoms worsen, or new symptoms appear, you should consult your doctor.

You should use the drug only according to the indications, the method of use and in the doses specified in the description.

Side effect

The incidence of side effects is classified according to who recommendations: very often-more than 10%; often-more than 1 and less than 10%; infrequently - more than 0.1 and less than 1%; rarely-more than 0.01 and less than 0.1%; very rarely-less than 0.01%.

From the skin: very rarely — urticaria, dermatitis, folliculitis.

Other: very rarely — inflammation of the salivary gland, acute laryngitis, rhinitis.

If the patient experiences or worsens the side effects listed in the description, or the patient has noticed any other side effects not listed in the description, you must inform your doctor.


Ismigen can be used simultaneously with other medications intended for the treatment of acute and chronic respiratory diseases.

Features of the interaction of the drug Ismigen with other drugs have not yet been described.

If the patient uses the above or other medications (including over-the-counter), consult a doctor before using Ismigen.


There is no information about overdose cases.

Special instruction

Children from 3 to 6 years of age should be supervised by adults during each dose until the tablet is completely dissolved in the oral cavity.

Influence on the ability to drive vehicles, mechanisms. Does not affect.

Form release

Sublingual tablets, 7 mg , 10 tabl. in contour cell packaging made of PVC film and aluminum foil. 1 or 3 contour cell packages in a pack of cardboard.

Conditions of supply of pharmacies

Without a prescription.


Bruschettini S. R. L., Italy. Genoa, Via Isonzo, 6.

Licensed by Lallemand Pharma, Switzerland.

Packed/name of the legal entity in whose name the registration certificate was issued: JSC Nizhfarm. 7, Salganskaya str., Nizhny Novgorod, 603950, Russia.

Tel.: (831) 278-80-88; Fax: (831) 430-72-28.


Complaints about the drug should be sent to the Federal service for supervision of health (Roszdravnadzor): 109074, Moscow, Slavyanskaya PL., 4, p. 1.


And to JSC Nizhfarm, Russia.

The appearance of the product may differ from the photos on the site.

Information about prescription drugs is for professionals only. The information provided should not be used by patients to make an independent decision on the use of the presented drugs and cannot serve as a substitute for a full-time consultation with a doctor.

A description of the active substances of the drug is provided. The scientific information provided is generalized and cannot be used to decide on the possibility of using a specific drug.

640,00 rub.
Product is available in pharmacies:
566,50 rub.
Product is available in pharmacies:
1 483,00 rub.
Product is available in pharmacies:
To the top